Literature DB >> 10353785

International variation in reported livebirth prevalence rates of Down syndrome, adjusted for maternal age.

A D Carothers1, C A Hecht, E B Hook.   

Abstract

Reported livebirth prevalence of Down syndrome (DS) may be affected by the maternal age distribution of the population, completeness of ascertainment, accuracy of diagnosis, extent of selective prenatal termination of affected pregnancies, and as yet unidentified genetic and environmental factors. To search for evidence of the latter, we reviewed all published reports in which it was possible to adjust both for effects of maternal age and for selective termination (where relevant). We constructed indices that allowed direct comparisons of prevalence rates after standardising for maternal age. Reference rates were derived from studies previously identified as having near complete ascertainment. An index value significantly different from 1 may result from random fluctuations, as well as from variations in the factors listed above. We found 49 population groups for which an index could be calculated. Methodological descriptions suggested that low values could often be attributed to under-ascertainment. A possible exception concerned African-American groups, though even among these most acceptable studies were compatible with an index value of 1. As we have reported elsewhere, there was also a suggestive increase in rates among US residents of Mexican or Central American origin. Nevertheless, our results suggest that "real" variation between population groups reported to date probably amounts to no more than +/-25%. However, reliable data in many human populations are lacking including, surprisingly, some jurisdictions with relatively advanced health care systems. We suggest that future reports of DS livebirth prevalence should routinely present data that allow calculation of an index standardised for maternal age and adjusted for elective prenatal terminations.

Entities:  

Mesh:

Year:  1999        PMID: 10353785      PMCID: PMC1734363     

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  40 in total

1.  Frequency of Down syndrome in livebirths by single-year maternal age interval: results of a Massachusetts study.

Authors:  E B Hook; J J Fabia
Journal:  Teratology       Date:  1978-06

2.  Differences in maternal age-specific rates of Down syndrome between Jews of European origin and of North African or Asian origin.

Authors:  E B Hook; S Harlap
Journal:  Teratology       Date:  1979-10

3.  Maternal age and Down syndrome: age-specific incidence rates by single-year intervals.

Authors:  B K Trimble; P A Baird
Journal:  Am J Med Genet       Date:  1978

4.  Maternal age specific risk rate estimates for Down syndrome among live births in whites and other races from Ohio and metropolitan Atlanta, 1970-1989.

Authors:  C A Huether; J Ivanovich; B S Goodwin; E L Krivchenia; V S Hertzberg; L D Edmonds; D S May; J H Priest
Journal:  J Med Genet       Date:  1998-06       Impact factor: 6.318

5.  Rates of Down syndrome at livebirth by one-year maternal age intervals in studies with apparent close to complete ascertainment in populations of European origin: a proposed revised rate schedule for use in genetic and prenatal screening.

Authors:  C A Hecht; E B Hook
Journal:  Am J Med Genet       Date:  1996-04-24

6.  Congenital malformations in Israel.

Authors:  H S Halevi
Journal:  Br J Prev Soc Med       Date:  1967-04

7.  Maternal age-specific rates for Down syndrome: changes over time.

Authors:  P A Baird; A D Sadovnick
Journal:  Am J Med Genet       Date:  1988-04

8.  The frequency of 47,+21,47,+18, and 47,+13 at the uppermost extremes of maternal ages: results on 56,094 fetuses studied prenatally and comparisons with data on livebirths.

Authors:  E B Hook; P K Cross; R R Regal
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

9.  Down's syndrome: percentage reporting on birth certificates and single year maternal age risk rates for Ohio 1970-79: comparison with upstate New York data.

Authors:  C A Huether; G R Gummere; E B Hook; P S Dignan; H Volodkevich; M Barg; D A Ludwig; S H Lamson
Journal:  Am J Public Health       Date:  1981-12       Impact factor: 9.308

10.  The natural history of cytogenetically abnormal fetuses detected at midtrimester amniocentesis which are not terminated electively: new data and estimates of the excess and relative risk of late fetal death associated with 47,+21 and some other abnormal karyotypes.

Authors:  E B Hook; B B Topol; P K Cross
Journal:  Am J Hum Genet       Date:  1989-12       Impact factor: 11.025

View more
  23 in total

Review 1.  MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.

Authors:  Bin Xu; Pei-Ken Hsu; Maria Karayiorgou; Joseph A Gogos
Journal:  Neurobiol Dis       Date:  2012-03-03       Impact factor: 5.996

2.  Increasing total prevalence rate of cases with Down syndrome in Hungary.

Authors:  Julia Métneki; Andrew E Czeizel
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  Current estimate of Down Syndrome population prevalence in the United States.

Authors:  Angela P Presson; Ginger Partyka; Kristin M Jensen; Owen J Devine; Sonja A Rasmussen; Linda L McCabe; Edward R B McCabe
Journal:  J Pediatr       Date:  2013-07-23       Impact factor: 4.406

Review 4.  MicroRNAs in psychiatric and neurodevelopmental disorders.

Authors:  Bin Xu; Maria Karayiorgou; Joseph A Gogos
Journal:  Brain Res       Date:  2010-04-10       Impact factor: 3.252

5.  Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease.

Authors:  Barbara J Strupp; Brian E Powers; Ramon Velazquez; Jessica A Ash; Christy M Kelley; Melissa J Alldred; Myla Strawderman; Marie A Caudill; Elliott J Mufson; Stephen D Ginsberg
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

6.  Prevalence and characteristics of abnormal head posture in children with Down syndrome: a 20-year retrospective, descriptive review.

Authors:  Alina V Dumitrescu; Daniela C Moga; Susannah Q Longmuir; Richard J Olson; Arlene V Drack
Journal:  Ophthalmology       Date:  2011-06-12       Impact factor: 12.079

7.  The effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by carbon 11-labeled Pittsburgh compound B.

Authors:  Patrick J Lao; Tobey J Betthauser; Ansel T Hillmer; Julie C Price; William E Klunk; Iulia Mihaila; Andrew T Higgins; Peter D Bulova; Sigan L Hartley; Regina Hardison; Rameshwari V Tumuluru; Dhanabalan Murali; Chester A Mathis; Annie D Cohen; Todd E Barnhart; Darlynne A Devenny; Marsha R Mailick; Sterling C Johnson; Benjamin L Handen; Bradley T Christian
Journal:  Alzheimers Dement       Date:  2015-06-13       Impact factor: 21.566

8.  Phonological accuracy and intelligibility in connected speech of boys with fragile X syndrome or Down syndrome.

Authors:  Elizabeth Barnes; Joanne Roberts; Steven H Long; Gary E Martin; Mary C Berni; Kerry C Mandulak; John Sideris
Journal:  J Speech Lang Hear Res       Date:  2009-08       Impact factor: 2.297

9.  Live births, natural losses, and elective terminations with Down syndrome in Massachusetts.

Authors:  Gert de Graaf; Frank Buckley; Brian G Skotko
Journal:  Genet Med       Date:  2016-04-14       Impact factor: 8.822

10.  Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.

Authors:  Christy M Kelley; Brian E Powers; Ramon Velazquez; Jessica A Ash; Stephen D Ginsberg; Barbara J Strupp; Elliott J Mufson
Journal:  Brain Pathol       Date:  2013-07-19       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.